Search - tctmd.com

Displaying 141 - 160 of 232

Sort: Relevancy | Date

Presentation

Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

Presenter: Kenneth Rosenfield

June 25, 2015

News Industry News

The New England Journal of Medicine publishes LEVANT 2 results for the Lutonix® Drug Coated Balloon, showing superior efficacy compared to standard PTA

June 25, 2015

Presentation CCVVC 2015

Covered Stents in Femoropopliteal Disease

Presenter: Subhash Banerjee

June 18, 2015

News Industry News

Boston Scientific And C. R. Bard Announce Distribution Agreement For Lutonix® Drug Coated Balloon

February 08, 2015

News Daily News

ISET Abstracts Shed Light on Novel Therapies for PAD

Caitlin E. Cox

February 04, 2015

News Features

药物涂层球囊获批标志着PAD治疗发生“重大变化”

L.A. McKeown

January 28, 2015

News Features

Las Aprobaciones de los Balones Recubiertos de Fármacos ‘Cambiarán’ el Tratamiento de la EAP

L.A. McKeown

January 28, 2015

News Features

Drug-Coated Balloon Approvals Mark ‘Sea Change’ for Treatment of PAD

L.A. McKeown

January 28, 2015

News Daily News

Drug-Coated Balloon Beats Angioplasty Alone in PAD Patients

Salynn Boyles

December 15, 2014

News Daily News

Los BRF son Mejores en Lesiones De Novo que en Lesiones Femoropoplíteas Reestenóticas

Caitlin E. Cox

October 24, 2014

News Daily News

DCB在原发性病变中的表现比在再狭窄股腘动脉病变中更好

Caitlin E. Cox

October 24, 2014

News Daily News

DCBs Perform Better in De Novo Compared With Restenotic Femoropopliteal Lesions

Caitlin E. Cox

October 24, 2014

News Industry News

The Lutonix® 035 Drug Coated Balloon is the First and Only FDA-Approved DCB Available in the U.S. for the Treatment of Femoropopliteal Occlusive Disease

October 10, 2014

News Daily News

Drug-Eluting Balloon Fails for Below-the-Knee Lesions in Critical Limb Ischemia Patients

Todd Neale

October 10, 2014

News Daily News

Registro MARIS: El Stent de Nitinol Parece Seguro y Efectivo en Pacientes AFS del ‘Mundo Real’

October 03, 2014

News Daily News

MARIS登记处：镍钛合金支架对“真实”SFA患者安全、有效

October 03, 2014

News Daily News

MARIS Registry: Nitinol Stent Appears Safe, Effective in ‘Real World’ SFA Patients

October 03, 2014

News Industry News

Randomized Study Demonstrates the Superiority of Laser Atherectomy for Treatment of In-Stent Restenosis in Patients with Femoropopliteal Peripheral Artery Disease

September 16, 2014

News Conference News TCT 2014

EXCITE ISR: Laser Atherectomy Superior to Angioplasty Alone for Femoropopliteal In-Stent Restenosis

September 16, 2014

Presentation TCT 2014

Bioresorbable Scaffolds: Status Update and Potential Role in Femoropopliteal Disease

Presenter: Robert M. Bersin, Dierk Scheinert, Roger Gammon, Mahmood K. Razavi

September 13, 2014

Advertisement

Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

The New England Journal of Medicine publishes LEVANT 2 results for the Lutonix® Drug Coated Balloon, showing superior efficacy compared to standard PTA

Covered Stents in Femoropopliteal Disease

Boston Scientific And C. R. Bard Announce Distribution Agreement For Lutonix® Drug Coated Balloon

ISET Abstracts Shed Light on Novel Therapies for PAD

药物涂层球囊获批标志着PAD治疗发生“重大变化”

Las Aprobaciones de los Balones Recubiertos de Fármacos ‘Cambiarán’ el Tratamiento de la EAP

Drug-Coated Balloon Approvals Mark ‘Sea Change’ for Treatment of PAD

Drug-Coated Balloon Beats Angioplasty Alone in PAD Patients

Los BRF son Mejores en Lesiones De Novo que en Lesiones Femoropoplíteas Reestenóticas

DCB在原发性病变中的表现比在再狭窄股腘动脉病变中更好

DCBs Perform Better in De Novo Compared With Restenotic Femoropopliteal Lesions

The Lutonix® 035 Drug Coated Balloon is the First and Only FDA-Approved DCB Available in the U.S. for the Treatment of Femoropopliteal Occlusive Disease

Drug-Eluting Balloon Fails for Below-the-Knee Lesions in Critical Limb Ischemia Patients

Registro MARIS: El Stent de Nitinol Parece Seguro y Efectivo en Pacientes AFS del ‘Mundo Real’

MARIS登记处：镍钛合金支架对“真实”SFA患者安全、有效

MARIS Registry: Nitinol Stent Appears Safe, Effective in ‘Real World’ SFA Patients

Randomized Study Demonstrates the Superiority of Laser Atherectomy for Treatment of In-Stent Restenosis in Patients with Femoropopliteal Peripheral Artery Disease

EXCITE ISR: Laser Atherectomy Superior to Angioplasty Alone for Femoropopliteal In-Stent Restenosis

Bioresorbable Scaffolds: Status Update and Potential Role in Femoropopliteal Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content